HubXchange San Francisco 2022 – March 31
Roundtable Discussion

Dan Norton
Personalis, Inc.
Thursday, March 31
Beyond MRD: Developing Patient-Centered Diagnostics through Tumor-Informed Comprehensive Insights
- Earlier detection of disease recurrence
- Utility in more disease indications, and at earlier stages of disease
- Clinical trial needs for patient enrichment
- Screening/enrollment
- Surrogate endpoint analysis
- Necessity for additional biomarker readouts
HubXchange San Francisco, March 31, 2022